Schonfeld Strategic Advisors’s Assembly Biosciences ASMB Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.34M	Buy	120,500 +66,265	+122%	+$1.89M	0.02%	619
2025 Q4	$1.84M	Sell	54,235 -67,653	-56%	-$2.18M	0.01%	903
2025 Q3	$3.12M	Buy	+121,888	New	+$2.67M	0.02%	815
2021 Q1	–	Sell	-24,989	Closed	-$1.81M	–	1779
2020 Q4	$1.81M	Buy	+24,989	New	+$2.93M	0.02%	621
2020 Q1	–	Sell	-2,999	Closed	-$736K	–	1130
2019 Q4	$736K	Buy	+2,999	New	+$552K	0.02%	598
2019 Q1	–	Sell	-2,567	Closed	-$697K	–	1041
2018 Q4	$697K	Sell	2,567 -1,066	-29%	-$308K	0.03%	561
2018 Q3	$1.62M	Sell	3,633 -200	-5%	-$93.7K	0.07%	332
2018 Q2	$1.8M	Buy	3,833 +2,638	+221%	+$1.39M	0.1%	287
2018 Q1	$704K	Buy	+1,195	New	+$741K	0.05%	402

Other funds holding ASMB

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Schonfeld Strategic Advisors's ASMB Position: Q1 2026 in Review

Schonfeld Strategic Advisors increased its Assembly Biosciences (ASMB) stake by 122% in Q1 2026, buying an estimated $1.89M and bringing the position to 120,500 shares worth $3.34M. The position accounts for 0.02% of the portfolio, ranked #619.

Schonfeld Strategic Advisors first reported a position in ASMB in Q1 2018 and has held it in 9 quarters since. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

Schonfeld Strategic Advisors held 120,500 shares of Assembly Biosciences worth $3.34M as of Q1 2026.
Schonfeld Strategic Advisors bought 66,265 Assembly Biosciences shares in Q1 2026, an estimated $1.89M.
Assembly Biosciences made up 0.02% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #619 holding.
Schonfeld Strategic Advisors first reported a position in Assembly Biosciences in Q1 2018 and has held it in 9 quarters since.
75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.